Alpha-synuclein — Drug Target

All drugs that target Alpha-synuclein — marketed and clinical-stage. Includes 2 drug classes acting on this target.

Drug classes

peptide · menatetrenone

Phase 2 pipeline (2)

• phytomenadione · Instituto Mexicano del Seguro Social · Cardiovascular
• Phylloquinone · Guy's and St Thomas' NHS Foundation Trust · Cardiovascular

Phase 1 pipeline (1)

• AFFITOPE® PD01A · Affiris AG · peptide · Neurology
  AFFITOPE® PD01A is designed to induce an immune response against alpha-synuclein, a protein implicated in Parkinson's disease.